NCT05986760

Comparsion of SPARK and Fundamental Motor Training

Completed NA Last updated 14 August 2023

What this trial tests

NA trial testing SPARK in Autism Spectrum Disorder in 18 participants. Completed in 27 May 2023.

Timeline

27 December 2022

Primary endpoint
27 May 2023

27 May 2023

Quick facts

Lead sponsor	khadija liaquat
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	18
Start date	27 December 2022
Primary completion	27 May 2023
Estimated completion	27 May 2023
Sites	1 location across Pakistan

Drugs / interventions tested

• SPARK

Conditions studied

• Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →

Sponsor

khadija liaquat

Who can join

Adults 5 to 9, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It was a Randomized Clinical Trial.Data will be collected from Life care rehabilitation and special child facility.The study was completed within 6 months after approval of synopsis.The

calculated sample size, through WHO sample size calculator, using Bruininks- Oseretsky test's mean and standard deviation (Mean Dynamic Balance) as outcome

measure was 20 in each group. After adding 10% dropout the sample size will be 20+4=24 in each group; hence, overall sample size n= 20. Age range 5-12 years. Children with diagnosed Autism and age ranges between 5-12 will be included in the study.Convenient Sampling Technique was used to collect the data.There was two groups.In Group A SPARK therapy will be provided and in group 2 fundamental motor skill training will be provided. To assess the social skills Gilliam Autism Rating Scale-Second Edition (GARS-2) and for motor skills Bruininkse Oseretsky test of motor proficiency (BOTMP) was used.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.